Greece strengthens its role in the global pharmaceutical market
In recent years, Greece has emerged as an important hub for the production and export of medicines in Europe. Our country is leveraging the momentum of the pharmaceutical sector by investing in new infrastructure and strengthening its domestic production base.
A characteristic example of this development is the company ELPEN, which is at the forefront of the industry's efforts. Through its strategy, the company demonstrates in practice the new direction being taken by the Greek pharmaceutical industry, combining innovation with high production capacity.
Strengthening this sector offers multiple benefits for the Greek economy. In addition to creating new jobs, the growth of the pharmaceutical industry helps the country's extroversion, as Greek products are now exported to many international markets.
This trend is expected to continue as Greece aims to attract more investment in the health and research sectors. In this way, the country is strengthening its position on the global map, offering reliable solutions to meet the needs of patients at an international level.